Cargando…

Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained

High-quality, safe, and effective biosimilars have the potential to increase access to biological therapies worldwide and to reduce cancer care costs. The European Medicines Agency (EMA) was the first regulatory authority to establish legislative procedures for the approval of biosimilars when they...

Descripción completa

Detalles Bibliográficos
Autores principales: Aapro, Matti, Krendyukov, Andriy, Schiestl, Martin, Gascón, Pere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878200/
https://www.ncbi.nlm.nih.gov/pubmed/29417431
http://dx.doi.org/10.1007/s40259-018-0262-9